Studies how migration and social conditions affect HIV control in migrants in France
Compares HIV treatment results in adult migrants according to their social and administrative situation.
Plain-language title generated from the registry record
Registry title: Impact of Migration History and Social Conditions on the Immuno-virological Control of HIV in Migrants in France
Key facts
- Where
- Clermont-Ferrand, FranceSee the site
Where in France
- Clermont-Ferrand University HospitalClermont-Ferrand, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Clermont-Ferrand
- Trial code
- NCT07691424
- Record updated
- 8 July 2026
- Original description
Migrants living with HIV - whether the infection was diagnosed in their country of origin or in France- frequently experience vulnerabilities related to their migration trajectories and often face socioeconomic and administrative instability upon arrival .Read full original descriptionShow less
Impact of Migration History and Social Conditions on the Immuno-virological Control of HIV in Migrants in France
Migrants living with HIV - whether the infection was diagnosed in their country of origin or in France- frequently experience vulnerabilities related to their migration trajectories and often face socioeconomic and administrative instability upon arrival .
The primary outcome of this study is to compare the immunovirological efficacy of antiretroviral therapy among migrants living with HIV patients according to their social and administrative status.
Inclusion: Adults (≥18 years of age); Migrant patients (i.e., individuals who entered France for the first time from another country) receiving care at Clermont-Ferrand University Hospital between January 1, 2010, and December 31, 2022, whose HIV infection was either known at the time of their arrival in France or diagnosed within 12 months after their arrival in France; Non-inclusion Criteria:; Patients who declined to participate in the study; Patients who do not speak French and for whom no interpretere was available; Adults subject to a legal protection measure (i.e., under guardianship, curatorship, or judicial protection).